Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MLXIPL Antikörper (AA 50-150)

MLXIPL Reaktivität: Human, Maus WB, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN540822
  • Target Alle MLXIPL Antikörper anzeigen
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Bindungsspezifität
    • 15
    • 14
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 50-150
    Reaktivität
    • 44
    • 25
    • 14
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 56
    • 3
    Kaninchen
    Klonalität
    • 56
    • 3
    Polyklonal
    Konjugat
    • 26
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MLXIPL Antikörper ist unkonjugiert
    Applikation
    • 35
    • 20
    • 20
    • 13
    • 13
    • 10
    • 9
    • 9
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of MLXIPL.
    Spezifität
    This antibody is specific to ChREBP.
    Kreuzreaktivität
    Human, Maus
    Produktmerkmale
    Antibody Reactive Against Synthetic Peptide.
    Immunogen
    A synthetic peptide corresponding to amino acids 50-150 of human MLXIPL.
    Top Product
    Discover our top product MLXIPL Primärantikörper
  • Applikationshinweise
    Immunofluorescence (1:100-1:500)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.01 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store at 4°C. Do not freeze.
  • Iizuka, Bruick, Liang, Horton, Uyeda: "Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 19, pp. 7281-6, (2004) (PubMed).

    Letexier, Pinteur, Large, Fréring, Beylot: "Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue." in: Journal of lipid research, Vol. 44, Issue 11, pp. 2127-34, (2003) (PubMed).

    Yamashita, Takenoshita, Sakurai, Bruick, Henzel, Shillinglaw, Arnot, Uyeda: "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 16, pp. 9116-21, (2001) (PubMed).

  • Target
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Andere Bezeichnung
    MLXIPL (MLXIPL Produkte)
    Synonyme
    ChREBP antikoerper, MLXIPL antikoerper, CHREBP antikoerper, MIO antikoerper, MONDOB antikoerper, WBSCR14 antikoerper, WS-bHLH antikoerper, bHLHd14 antikoerper, Wbscr14 antikoerper, MLX interacting protein-like antikoerper, MLX interacting protein like antikoerper, MLXIPL antikoerper, Mlxipl antikoerper
    Gen-ID
    51085
    Pathways
    Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Sie sind hier:
Kundenservice